Gkcc, LLC

Gkcc, LLC insider trades: Elicio Therapeutics (ELTX) stock purchases

Elicio Therapeutics Last trade Dec 22, 2023 6 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
1
Open-market trades
since 2023
1
Company
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gkcc, LLC reports to the SEC

Open-market buys and sales

1 trade reported on SEC Form 4, newest first

DateStockTypeValue
Dec 22, 2023ELTX↑ Buy$7.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Gkcc, LLC's insider trades

Gkcc, LLC is an insider at Elicio Therapeutics (ELTX). Since Dec 22, 2023, it has reported 1 open-market purchase worth $7.0M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (3 filings), grants and awards (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ELTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.